Sunshine Lake Pharma Makes History With Dual-Entity Restructuring Listing on HKEX
Guangdong China-based Sunshine Lake Pharma Co., Ltd. (HKG: 6887) has successfully listed on the Main...
Sunshine Lake Pharma
Sunshine Lake Pharma Lists on HKEX via Introduction Method
China-based Sunshine Lake Pharma Co., Ltd. (HKG: 6887) has successfully listed on the Main Board...
NMPA Approves Sinocelltech’s Finotonlimab for Head and Neck Cancer
The National Medical Products Administration (NMPA) of China has approved Sinocelltech Group Ltd’s (SHA: 688520)...
Sunshine Lake Pharma Files for HKEX IPO, Expanding Global Pharmaceutical Reach
China-based Sunshine Lake Pharma Co., Ltd has submitted an initial public offering (IPO) filing to...
3SBio Inc. Secures Licensing Deal with Sunshine Lake Pharma for Clifutinib Commercialization
China-based 3SBio Inc. (HKG: 1530) has announced a licensing deal with fellow Chinese firm Sunshine...
Sunshine Lake Pharma Inks Licensing Deal with Apollo Therapeutics for APL-18881
China-based Sunshine Lake Pharma Co., Ltd., (HKG: 1558) a member of the HEC Group, has...
HEC Pharma Overturns Patent Decision Against Novartis’ Gilenya
China-based generics firm HEC Pharma has managed to overturn a previous final decision in a...